SCHEMBL1834141

SCHEMBL1834141

NS(=O)(=O)CCCCCCOCCN1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.47
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
EPHX2 P34913 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
KEAP1 Q14145 1/20 0.43
TSHR P16473 1/20 0.40
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1830035 1.00 HRH3 (0.47) HRH3CA12CA1CA2CA7
SCHEMBL2204107 1.00 HRH3 (0.47) HRH3CA12CA1CA2CA7
SCHEMBL2183875 0.87 SMN1; SMN2 (0.52) HRH3CA12CA1CA2CA7
SCHEMBL1830508 0.87 SMN1; SMN2 (0.52) HRH3CA12CA1CA2CA7
SCHEMBL20762021 0.85 KEAP1 (0.53) HRH3CA12CA1CA2CA7
SCHEMBL1447319 0.84 KEAP1 (0.55) HRH3CA12CA1CA2CA7
SCHEMBL23471239 0.79 KEAP1 (0.66) HRH3EPHX2SMN1; SMN2KEAP1TSHR
SCHEMBL9812536 0.78 SMN1; SMN2 (0.56) HRH3SMN1; SMN2KEAP1TSHRKDM4E
SCHEMBL1830494 0.77 EPHX2 (0.53) EPHX2SMN1; SMN2KEAP1KDM4EALDH1A1
SCHEMBL1831207 0.77 EPHX2 (0.53) EPHX2SMN1; SMN2KEAP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342181-A1 NOVEL UREA AND THIOUREA DERIVATIVES Topo Target A/S (DK) 2011-07-13 EP disclosed
EP-2318369-A1 SQUARIC ACID DERIVATIVES AS INHIBITORS OF THE NICOTINAMIDE TopoTarget A/S (DK) 2011-05-11 EP disclosed
WO-2010066709-A1 NOVEL PYRIDINYL ACRYLAMIDE DERIVATIVES TOPOTARGET A/S (DK) 2010-06-17 WO disclosed